Latest News

Concordia Healthcare Completes AMCo Acquisition

Concordia Healthcare Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR) announced today that it has completed the acquisition of Amdipharm Mercury Limited ("AMCo") from Cinven and certain other sellers, concurrently with the closing of its debt financing.

"This is a tremendous milestone for Concordia. This acquisition has transformed us from a predominantly U.S. business to a leading, international pharmaceutical company," said Mark Thompson, Concordia's founder, Chairman and Chief Executive Officer. "We now have a combined portfolio of more than 200 established products and an extensive geographic platform that spans over 100 countries. This combination creates a powerful global platform for our continued organic growth and significantly diversifies our business, while generating strong free cash flows to pay down our current debt and reinvest in the continued growth of our business."

For more information, please see http://concordiarx.com/concordia-healthcare-completes-amco-acquisition/ or contact:

 

Marija Mandic
Concordia Healthcare Corp.
905-842-5150 x 240
mmandic@concordiarx.com